Therapeutics

Ladostigil Hemitartrate

Tools

Back to the Top

Overview

Name: Ladostigil Hemitartrate
Synonyms: TV-3,326
Therapy Type: Small Molecule (timeline)
Target Type: Cholinergic System (timeline)
Condition(s): Mild Cognitive Impairment
U.S. FDA Status: Mild Cognitive Impairment (Phase 2)
Company: Avraham Pharmaceuticals Ltd

Background

Comments

Make a Comment

To make a comment you must login or register.

Comments on this content

No Available Comments

References

No Available References

Further Reading

No Available Further Reading